MHH-NB-11Homo sapiens (Human)Cancer cell line

Also known as: MHHNB11, MHH-NB11

🤖 AI SummaryBased on 6 publications

Quick Overview

MHH-NB-11 is a human neuroblastoma cell line used in cancer research.

Detailed Summary

MHH-NB-11 is a human neuroblastoma cell line derived from a tumor, commonly used in cancer research to study the biology and treatment of neuroblastoma. This cell line is part of a collection of cell lines used for understanding the genetic and molecular characteristics of neuroblastoma. It is utilized in studies involving drug sensitivity, gene expression, and tumor biology. The cell line is also part of the Cancer Cell Line Encyclopedia (CCLE) and has been analyzed for its genomic and transcriptomic features, contributing to the understanding of cancer mechanisms and potential therapeutic targets.
Generated on 6/17/2025

Basic Information

Database IDCVCL_1412
SpeciesHomo sapiens (Human)
Tissue SourceAdrenal gland[UBERON:UBERON_0002369]

Donor Information

Age4
Age CategoryPediatric
SexMale
Racecaucasian
Subtype FeaturesMYC_Amplified

Disease Information

DiseaseNeuroblastoma
LineagePeripheral Nervous System
SubtypeNeuroblastoma
OncoTree CodeNBL

DepMap Information

Source TypeDSMZ
Source IDACH-000078_source

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
12
D13S317
12
D16S539
9,13
D18S51
16,17
D19S433
13,17
D21S11
30,31.2
D2S1338
24
D3S1358
15,17
D5S818
11
D7S820
8,9
D8S1179
13,14
FGA
20,21
Penta D
11,12
Penta E
5,12
TH01
7,9.3
TPOX
8
vWA
16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Immunocytochemical analysis of cell lines derived from solid tumors.

Quentmeier H., Osborn M., Reinhardt J., Zaborski M., Drexler H.G.

J. Histochem. Cytochem. 49:1369-1378(2001).

Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastoma.

Kovacs G.

Anticancer Res. 8:1329-1333(1988).

Tumor cell lines of the peripheral nervous system.";

Israel M.A., Thiele C.J.

(In book chapter) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.43-78; Academic Press; New York; USA (1994).